Information Provided By: 
Fly News Breaks for June 10, 2015
BCRX, ALKS, ACT, VSTM, TSRO, CLVS
Jun 10, 2015 | 05:52 EDT
Mizuho analyst Peter Lawson highlighted his top names in biotech ahead of expected catalysts in the second half of 2015. In the biotech space, Lawson likes Clovis (CLVS), TESARO (TSRO) and Verastem (VSTM). In biopharma, Lawson likes Actavis (ACT), Alkermes (ALKS) and BioCryst (BCRX). The analyst expects expect FDA approval of TESARO's first drug, rolapitant, in September. He views Alkermes' central nervous system pipeline as being underappreciated at current share levels.
News For CLVS;TSRO;VSTM;ACT;ALKS;BCRX From the Last 2 Days
